Legal Representation
Attorney
Ilene B. Tannen
USPTO Deadlines
Next Deadline
22 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
August 27, 2025
Extension Available
Until February 27, 2025
Application History
29 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jun 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 25, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Jun 25, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jan 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 30, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 30, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jan 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 26, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 26, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 26, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 26, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 27, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jan 2, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 2, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Dec 13, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Nov 27, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 27, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Nov 27, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 27, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 27, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Aug 29, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 29, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 29, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 9, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 10, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Nov 9, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 29, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals, and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; vaccines; pharmaceutical preparations for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; biopharmaceuticals in the nature of pharmaceutical preparations for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; therapeutic pharmaceuticals for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; diagnostic substances, preparations, and agents for medical purposes
Class 042
Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials; Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells
Additional Information
Design Mark
The mark consists of a design of a circle that contains four connected lines, one of which extends past the outside of the circle. The lines form one incomplete triangle and one complete triangle. At the end of each line is a small shaded circle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042